Efficacy of liraglutide in pediatric obesity: A review of clinical trial data
The most frequent adverse effects are gastrointestinal and dose-related: Nausea, vomiting, diarrhoea, constipation, and abdominal discomfort - Typically worst during dose escalation and often resolve or attenuate with continued treatment and slower titration
Why do some peptides sting or leave a welt at the injection site
Clin J Am Soc Nephrol 2007;2:631-6.ArticlePubMed 11
The 4 mg dose group, which many researchers consider the starting therapeutic range for retatrutide protocols , showed more modest heart rate elevations in the 2 to 4 beat per minute range
He provides physician-supervised obesity treatment, including GLP-1based weight management and advanced bariatric surgery